Modulation of c-fins proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme
1997

Using Ribozyme to Target c-fms in Ovarian Cancer Cells

Sample size: 9 publication Evidence: moderate

Author Information

Author(s): Y Yokoyama, S Morishita, Y Takahashi, M Hashimoto, T Tamaya

Primary Institution: Gifu University School of Medicine

Hypothesis

Can hammerhead ribozymes effectively block the autocrine loop of M-CSF in ovarian epithelial carcinoma cells?

Conclusion

The ribozyme targeting c-fms mRNA significantly reduced cell growth in ovarian carcinoma cells.

Supporting Evidence

  • The ribozyme against codon 18 of c-fms mRNA was more effective than that against codon 27.
  • Transfectants with the ribozyme showed reduced growth potential compared to controls.
  • c-fms protein and mRNA levels decreased in transfectants expressing the ribozyme.

Takeaway

Researchers created a special tool called a ribozyme to stop cancer cells from growing by blocking a signal they use to grow.

Methodology

The study involved creating ribozymes to target specific mRNA sequences in ovarian carcinoma cells and measuring the effects on cell growth.

Limitations

The ribozyme could not completely eliminate c-fms expression, indicating potential challenges in targeting mRNA.

Participant Demographics

Ovarian epithelial carcinoma tissues from nine patients were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication